Anders Martin-Lof has been appointed chief financial officer at Wilson Therapeutics AB which is developing a treatment for Wilson’s disease, a rare autosomal disorder. Mr Martin-Lof was most recently CFO of Extenda, a privately-held software company and before that, CFO of RaySearch Laboratories AB, a medical technology company. He has also been a management consultant at the Boston Consulting Group.
Wilson Therapeutics announced the appointment on 3 November 2015.
Copyright 2015 Evernow Publishing Ltd